Synthesis and action on the central nervous system of some N2-substituted cinnoline derivatives. 1994

A Stańczak, and W Kwapiszewski, and A Szadowska, and W Pakulska
Department of Pharmaceutical Chemistry and Drug Analysis, Medical University, Lódź, Poland.

Alkylation of 4-hydroxycinnolines using ethyl bromoacetate resulted in N2-substituted acetic acids. These acids were converted to esters and amides. Some of the obtained acids were reduced with zinc dust to give 4-oxo-1,2,3,4-tetrahydro-2-cinnolineacetic acids. Several of the compounds were tested for their effect on central nervous system.

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010793 Phthalazines Bicyclic heterocyclic compounds containing a BENZENE ring fused to PYRIDAZINE.
D002491 Central Nervous System Agents A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into "specific" agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and "nonspecific" agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with nonspecific mechanisms are generally further classed according to whether they produce behavioral depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use. (From Gilman AG, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p252) Central Nervous System Drugs
D002627 Chemistry, Physical The study of CHEMICAL PHENOMENA and processes in terms of the underlying PHYSICAL PHENOMENA and processes. Physical Chemistry,Chemistries, Physical,Physical Chemistries
D005260 Female Females
D000661 Amphetamine A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE. Desoxynorephedrin,Levoamphetamine,Phenopromin,l-Amphetamine,Amfetamine,Amphetamine Sulfate,Amphetamine Sulfate (2:1),Centramina,Fenamine,Mydrial,Phenamine,Thyramine,levo-Amphetamine,Sulfate, Amphetamine,l Amphetamine,levo Amphetamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

A Stańczak, and W Kwapiszewski, and A Szadowska, and W Pakulska
January 1987, Indian journal of physiology and pharmacology,
A Stańczak, and W Kwapiszewski, and A Szadowska, and W Pakulska
March 1975, Acta pharmaceutica Hungarica,
A Stańczak, and W Kwapiszewski, and A Szadowska, and W Pakulska
July 1946, Journal of the American Chemical Society,
A Stańczak, and W Kwapiszewski, and A Szadowska, and W Pakulska
January 2001, Acta poloniae pharmaceutica,
A Stańczak, and W Kwapiszewski, and A Szadowska, and W Pakulska
December 1972, Journal of medicinal chemistry,
A Stańczak, and W Kwapiszewski, and A Szadowska, and W Pakulska
January 1966, Archivum immunologiae et therapiae experimentalis,
A Stańczak, and W Kwapiszewski, and A Szadowska, and W Pakulska
January 1954, Archivio di scienze biologiche,
A Stańczak, and W Kwapiszewski, and A Szadowska, and W Pakulska
January 1994, Acta poloniae pharmaceutica,
A Stańczak, and W Kwapiszewski, and A Szadowska, and W Pakulska
April 1946, Nature,
A Stańczak, and W Kwapiszewski, and A Szadowska, and W Pakulska
January 1957, Journal de physiologie,
Copied contents to your clipboard!